EXKIVITY vs LUMAKRAS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. EXKIVITY and LUMAKRAS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EXKIVITY	LUMAKRAS
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	MOBOCERTINIB SUCCINATE	SOTORASIB
Manufacturer	Takeda Pharms USA	Amgen Inc
Dosage forms	Capsule	Tablet
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Non-Small-Cell Lung Carcinoma

exkivity lumakras

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

MOBOCERTINIB SUCCINATE

SOTORASIB

Manufacturer

Takeda Pharms USA

Amgen Inc

Dosage forms

Capsule

Tablet

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Exkivity and Lumakras?

Exkivity contains Mobocertinib Succinate, while Lumakras contains Sotorasib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.